- Home
- MIND vs QNCX Comparison
MIND vs QNCX Comparison
Compare MIND & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- QNCX
- Stock Information
- Founded
- MIND 1987
- QNCX 2012
- Country
- MIND United States
- QNCX United States
- Employees
- MIND N/A
- QNCX N/A
- Industry
- MIND Industrial Machinery/Components
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MIND Industrials
- QNCX Health Care
- Exchange
- MIND Nasdaq
- QNCX Nasdaq
- Market Cap
- MIND 53.6M
- QNCX 43.2M
- IPO Year
- MIND 1994
- QNCX 2019
- Fundamental
- Price
- MIND $6.07
- QNCX $1.04
- Analyst Decision
- MIND
- QNCX Strong Buy
- Analyst Count
- MIND 0
- QNCX 5
- Target Price
- MIND N/A
- QNCX $8.00
- AVG Volume (30 Days)
- MIND 97.6K
- QNCX 611.7K
- Earning Date
- MIND 06-10-2025
- QNCX 05-13-2025
- Dividend Yield
- MIND N/A
- QNCX N/A
- EPS Growth
- MIND N/A
- QNCX N/A
- EPS
- MIND 4.32
- QNCX N/A
- Revenue
- MIND $46,863,000.00
- QNCX N/A
- Revenue This Year
- MIND $7.28
- QNCX N/A
- Revenue Next Year
- MIND N/A
- QNCX N/A
- P/E Ratio
- MIND $1.41
- QNCX N/A
- Revenue Growth
- MIND 28.36
- QNCX N/A
- 52 Week Low
- MIND $3.05
- QNCX $0.51
- 52 Week High
- MIND $11.10
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- MIND 41.81
- QNCX 49.33
- Support Level
- MIND $6.21
- QNCX $0.93
- Resistance Level
- MIND $6.62
- QNCX $1.06
- Average True Range (ATR)
- MIND 0.30
- QNCX 0.11
- MACD
- MIND -0.08
- QNCX 0.02
- Stochastic Oscillator
- MIND 5.60
- QNCX 76.19
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.